Pulmonx
Jonathon Bennett is a Cost Accountant at Pulmonx Corporation since July 2022, with prior experience at SureCall where roles included Cost Accountant and Staff Accountant from June 2020 to July 2022. Educational qualifications include a Bachelor's degree in Finance from San Diego State University (2019-2021) and an Associate of Science in Finance from De Anza College (2017-2019).
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1